Loading...
•
Dec 31, 2023
Teladoc Q4 2023 Earnings Report
Teladoc Health's revenue increased, and net loss decreased significantly compared to the previous year.
Key Takeaways
Teladoc Health reported a 4% increase in revenue for Q4 2023, reaching $660.5 million. The net loss was $28.9 million, a significant improvement from the $3,810.1 million loss in Q4 2022. Adjusted EBITDA increased by 22% to $114.4 million. The company provided financial guidance for Q1 2024 and the full year 2024.
Q4 2023 revenue increased by 4% year-over-year to $660.5 million.
Net loss for Q4 2023 was $28.9 million, a substantial improvement from the $3,810.1 million loss in Q4 2022.
Adjusted EBITDA for Q4 2023 increased by 22% to $114.4 million.
The company initiates 2024 guidance, projecting revenue between $2.635 and $2.735 billion and adjusted EBITDA between $350 and $390 million.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Teladoc Health provided financial guidance for the first quarter and full year of 2024.
Positive Outlook
- Revenue: $630 - $645 million (Q1 2024)
- Revenue: $2,635 - $2,735 million (Full Year 2024)
- Adjusted EBITDA: $52 - $62 million (Q1 2024)
- Adjusted EBITDA: $350 - $390 million (Full Year 2024)
- Free Cash Flow: $210 - $240 million (Full Year 2024)
Challenges Ahead
- Net loss per share: ($0.55) - ($0.45) (Q1 2024)
- Net loss per share: ($1.10) - ($0.80) (Full Year 2024)
- BetterHelp Revenue growth percentage (year-over-year): (6%) - (3%) (Q1 2024)
- Integrated CareRevenue growth percentage (year-over-year)5% - 7% (Q1 2024)
- BetterHelpRevenue growth percentage (year-over-year)Flat to low-single-digits (Full Year 2024)
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...